Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:

Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Tim Stenovec, Carol Massar
- Airbnb (ABNB) Chief Executive Officer Brian Chesky said his company is back in “growth mode” after it posted the fastest revenue gain in three years. The company now expects full-year revenue to grow in the “high teens” and lifted its full-year margin forecast for adjusted earnings before interest, taxes, depreciation and amortization to about 36%. Airbnb announced a new repurchase authorization of as much as $12 billion more in stock and shares jumped more than 10% in extended trading after the release.

- Moderna (MRNA) boosted its full-year guidance and posted its first quarterly profit since 2024 as Covid vaccine sales rebounded strongly from a year ago. The company is trying to open a new source of growth by refocusing on cancer drug development, with a successful late-stage trial of an mRNA-based skin cancer vaccine with Merck & Co. Moderna anticipates filing a US marketing application for the cancer drug, called intismeran, by the end of the year, which could lead to approval in 2027.

- DraftKings (DKNG) shares fell as much as 29% on Friday after the company sharply reduced its profit forecast as a result of continued investment in its prediction-market product. The company now expects revenue of as much as $6.55 billion and adjusted earnings before interest, tax, depreciation and amortization up to $275 million for fiscal year 2026. DraftKings reported revenue of $1.33 billion in the third quarter, missing analysts’ estimates of $1.39 billion, and sees adjusted Ebidta for 2027 of $800 million to $1 billion.